{
  "id": "1d81dbdbc19740f6",
  "title": "FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer",
  "description": "20260217T190000Z",
  "content": "",
  "source": "oncologynurseadvisor.com",
  "source_url": "https://www.oncologynurseadvisor.com/news/fda-approves-optune-pax-for-locally-advanced-pancreatic-cancer/",
  "published_at": "20260217T190000Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.oncologynurseadvisor.com/news/fda-approves-optune-pax-for-locally-advanced-pancreatic-cancer/",
    "url_mobile": "",
    "title": "FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer",
    "seendate": "20260217T190000Z",
    "socialimage": "",
    "domain": "oncologynurseadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}